| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Dec―17 |
Retraction notice to “Novel dynamic fuzzy decision-making framework for COVID-19 vaccine dose recipients” [J. Adv. Res. 37 (2022) 147-168] |
O.S. Albahri, A.A. Zaidan, A.S. Albahri, H.A. Alsattar, Rawia Mohammed, Uwe Aickelin, Gang Kou, F.M. Jumaah, Mahmood M. Salih, A.H. Alamoodi, B.B. Zaidan, Mamoun Alazab, Alhamzah Alnoor, Jameel R. Al-Obaidi |
| 2 |
[GO] |
2025―Oct―12 |
Ganoderma lucidum spore powder enhances IFN-α-mediated antiviral capacity of COVID-19 vaccine boosters revealed by single-cell multi-omics sequencing |
Anyao Li, Xiaoyan Lu, Rongfang Guo, Wenbo Guo, Penghui Yang, He Lou, Jie Chen, Enshan Huang, Ronghua Zhang, Hanbo Wang, Jihong Yang, Zhenhao Li, Xiaohui Fan |
| 3 |
[GO] |
2025―May―10 |
SARS-CoV-2 damages cardiomyocyte mitochondria and implicates long COVID-associated cardiovascular manifestations |
Wenliang Che, Shuai Guo, Yanqun Wang, Xiaohua Wan, Bingyu Tan, Hailing Li, Jiasuer Alifu, Mengyun Zhu, Zesong Chen, Peiyao Li, Lei Zhang, Zhaoyong Zhang, Yiliang Wang, Xiaohan Huang, Xinsheng Wang, Jian Zhu, Xijiang Pan, Fa Zhang, Peiyi Wang, Sen-Fang Sui, Jincun Zhao, Yawei Xu, Zheng Liu |
| 4 |
[GO] |
2025―May―09 |
Palmitoylated COX-2Cys555 reprogrammed mitochondrial metabolism in pyroptotic inflammatory injury in patients with post-acute COVID-19 syndrome |
Jia-Shen Wu, Chi-Yu Xu, Su-Min Mo, Xin-Mou Wu, Ze-Bang Du, Lin Che, Yi-Ling Zhang, Kai-Li Yang, Ting-Dong Li, Sheng-Xiang Ge, Tian-Ying Zhang, Zhong-Ning Lin, Yu-Chun Lin |
| 5 |
[GO] |
2024―Dec―11 |
Key β1-4 galactosylated glycan receptors of SARS-CoV-2 and its inhibitor from the galactosylated glycoproteins of bovine milk |
Hanjie Yu, Wentian Chen, Jian Shu, Xin Wu, Jia Quan, Hongwei Cheng, Xiaojuan Bao, Di Wu Resource, Xilong Wang, Zheng Li |
| 6 |
[GO] |
2024―Nov―09 |
Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms |
Abbas F. Almulla, Michael Maes, Bo Zhou, Hussein K. Al-Hakeim, Aristo Vojdani |
| 7 |
[GO] |
2023―Nov―27 |
Harnessing peptide and nanoparticle technology for developing innovative vaccination strategy against COVID-19 |
Hassan Elsayed, Rehab Moustafa, Reem Fathy, Sherine N. Khattab, Mona M. Agwa, Eman Mahmoud, Mohammed A. Sarhan, Mohamed Mostafa Abdel Ghafar, Mohamed El-Shiekh, Ahmed A. Yousif, Maysa Hanfi Shaker, Mohamed Elkasas, Ahmed H. Farag, Weam Goda, Sherif M. Shawky, Amani A. Mostafa, Ali M. Zaki |
| 8 |
[GO] |
2023―Nov―27 |
Challenges facing hepatitis B infected population during the COVID-19 crisis, how far are we? |
Mahmoud Essam, Abdelhamed A. Salem, Amany Ahmed Salem, Sherief Abd-Elsalam, Ossama Ashraf Ahmed, Amira Mahmoud Al Balakosy, Ehab F. Moustafa, Sahar M. Hassany, Mina Tharwat, Ahmed Cordie, Gamal Esmat |
| 9 |
[GO] |
2023―Nov―27 |
Does angiotensin converting enzyme (ACE) receptor genetic polymorphism has a role in COVID-19 infection outcome? |
Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elhawary, Abdel-Hady El-Gilany, Hosam Zaghloul, Mohamed Elegezy, Ahmed Elnakib |
| 10 |
[GO] |
2023―Nov―27 |
Association of Interleukin-6(IL-6) and IL-10 genetic polymorphism with the severity of COVID-19 patients |
Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elnakib, Ahmed Elhawary, Abdel-Hady El-Gilany, Hosam Zaghloul, Mohamed Elegezy |
| 11 |
[GO] |
2023―Nov―27 |
Extra corporeal therapy in critically ill COVID-19 patients: Is it the savior? |
Samy Zaky, Mohamed Elbadry, Hoda A Makhlouf, Sherif Abd El-Salam, Tarik S. Sarhan, Noha H. Eltaweel, Heba Aly, Akram Abdelbary, Ahmad Said, Mohammed Hamdy Farouk, Amin Abdel Baki, Hanaa Fathelbab, Reham Hammad, Fathiya El-Raey |
| 12 |
[GO] |
2023―Oct―04 |
Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19 |
Qiaohui Du, Ronghui Liang, Meiling Wu, Minxiao Yang, Yubin Xie, Qing Liu, Kaiming Tang, Xiang Ling, Shuofeng Yuan, Jiangang Shen |
| 13 |
[GO] |
2023―Aug―08 |
Modifications of Lipid Pathways Restrict SARS-CoV-2 Propagation in Human Induced Pluripotent Stem Cell-derived 3D Airway Organoids |
Ping-Hsing Tsai, Jun-Ren Sun, Yueh Chien, Man Sheung Chan, Winnie Khor, Hsin-Chou Yang, Chih-Heng Huang, Chia-Ni Hsiung, Teh-Yang Hwa, Yi-Ying Lin, Chih-Ling Yeh, Mong-Lien Wang, Yi-Ping Yang, Yuh-Min Chen, Fu-Ting Tsai, Meng-Shiue Lee, Yun-Hsiang Cheng, Shan-Ko Tsai, Ping-Cheng Liu, Shih-Jie Chou, Shih-Hwa Chiou |
| 14 |
[GO] |
2023―Feb―25 |
Corrigendum to “Novel dynamic fuzzy Decision-Making framework for COVID-19 vaccine dose recipients” [J. Adv. Res. 37 (2022) 147-168] |
O.S. Albahri, A.A. Zaidan, A.S. Albahri, H.A. Alsattar, Rawia Mohammed, Uwe Aickelin, Gang Kou, FM. Jumaah, Mahmood M. Salih, A.H. Alamoodi, B.B. Zaidan, Mamoun Alazab, Alhamzah Alnoor, Jameel R. Al-Obaidie |
| 15 |
[GO] |
2021―Nov―26 |
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome |
Olga A. Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, SabbaRao V. Madhunapantula, Mikhail Sinelnikov, Vladimir N. Nikolenko, Margarita E. Neganova, Sergey G. Klochkov, Mohammad Amjad Kamal, Sonya Marshall-Gradisnik, Donald R Staines |
| 16 |
[GO] |
2021―Nov―26 |
Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients |
Qing Lei, Cai-zheng Yu, Yang Li, Hong-yan Hou, Zhao-wei Xu, Zong-jie Yao, Yan-di Zhang, Dan-yun Lai, Jo-Lewis Banga Ndzouboukou, Bo Zhang, Hong Chen, Zhu-qing Ouyang, Jun-biao Xue, Xiao-song Lin, Yun-xiao Zheng, Xue-ning Wang, He-wei Jiang, Hai-nan Zhang, Huan Qi, Shu-juan Guo, Mei-an He, Zi-yong Sun, Feng Wang, Sheng-ce Tao, Xiong-lin Fan |
| 17 |
[GO] |
2021―Nov―26 |
Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection |
Yang Yi, Junhua Li, Xinyuan Lai, Meng Zhang, Yi Kuang, Yang-Oujie Bao, Rong Yu, Wei Hong, Elishiba Muturi, Heng Xue, Hongping Wei, Tong Li, Hui Zhuang, Xue Qiao, Kuanhui Xiang, Hang Yang, Min Ye |
| 18 |
[GO] |
2021―Nov―16 |
The role of mild and asymptomatic infections on COVID-19 vaccines performance: a modeling study |
Maíra Aguiar, Joseba Bidaurrazaga Van-Dierdonck, Javier Mar, Nico Stollenwerk |
| 19 |
[GO] |
2021―Nov―09 |
Virucidal and biodegradable specialty cellulose nonwovens as personal protective equipment against COVID-19 pandemic |
Chao Deng, Farzad Seidi, Qiang Yong, Xiangyu Jin, Chengcheng Li, Ling Zheng, Zhenghong Yuan, Huining Xiao |
| 20 |
[GO] |
2021―Aug―21 |
Novel Dynamic Fuzzy Decision-Making Framework for COVID-19 Vaccine Dose Recipients |
O.S. Albahri, A.A. Zaidan, A.S. Albahri, HA. Alsatta, R. Mohammed, Uwe Aickelin, Gang Kou, FM. Jumaah, M.M. Salih, A.H. Alamoodi, B.B. Zaidan, Mamoun Alazab, A. Alnoor, J.R. Al-Obaidi |
| 21 |
[GO] |
2021―Jul―27 |
Longitudinal and Proteome-wide Analyses of Antibodies in COVID-19 Patients Reveal Features of the Humoral Immune Response to SARS-CoV-2 |
Jianxin Wang, Yongfei Yang, Te Liang, Ning Yang, Tao Li, Chang Zheng, Nianzhi Ning, Deyan Luo, Xiaolan Yang, Zhili He, Guang Yang, Bo Li, Jie Gao, Wenjing Yu, Saisai Gong, Yanyu Huang, Jiajia Li, Hongye Wang, Hao Zhang, Tian Zhang, Peiran Li, Yongli Li, Jiayu Dai, Xiaomei Zhang, Boan Li, Xiaobo Yu, Hui Wang |
| 22 |
[GO] |
2021―Jul―22 |
Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection |
Vijayakumar Jawalagatti, Perumalraja Kirthika, Ji-Young Park, Chamith Hewawaduge, John Hwa Lee |
| 23 |
[GO] |
2021―Jan―10 |
Recovery scenario and immunity in COVID-19 disease: a new strategy to predict the potential of reinfection |
Zahra Khoshkam, Younes Aftabi, Peter Stenvinkel, B. Paige Lawrence, Mehran Habibi Rezaei, Gaku Ichihara, Sasan Fereidouni |
| 24 |
[GO] |
2020―Nov―26 |
Genomic characterization of SARS-CoV-2 in Egypt |
Abdel-Rahman N. Zekri, Khaled Easa Amer, Mohammed M Hafez, Zeinab K. Hassan, Ola S Ahmed, Hany K. Soliman, Abeer A. Bahnasy, Wael Abdel Hamid, Ahmad Gad, Mahmoud Ali, Wael Hassan, Mahmoud Samir, Ahmad Raouf, Ayman A. Khattab, Mona Salah El Din Hamdy, May Sherif Soliman, Maha Hamdi El Sissy, Sara Mohamed El khateeb, Moushira Hosny Ezzelarab, Lamiaa A Fathalla, Mohamed Abouelhoda |
| 25 |
[GO] |
2020―Aug―25 |
A hybrid fractional optimal control for a novel Coronavirus (2019-nCov) mathematical model |
N.H. Sweilam, S.M. AL-Mekhlafi, D. Baleanu |
| 26 |
[GO] |
2020―Aug―06 |
Molecular diagnostic technologies for COVID-19: Limitations and challenges |
Adeel Afzal |
| 27 |
[GO] |
2020―Mar―16 |
COVID-19 infection: origin, transmission, and characteristics of human coronaviruses |
Muhammad Adnan Shereen, Suliman Khan, Abeer Kazmi, Nadia Bashir, Rabeea Siddique |
|
